Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728.SZ

17.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009
Revenue 687.7851,067.212886.571758.16632.695921.122884.976686.944655.857516.54344.748342.721340.827305.131250.808202.139
Cost of Revenue 385.712467.988451.833356.076327.088374.504363.842355.743342.735282.662192.398193.791198.75183.679163.56151.392
Gross Profit 302.073599.224434.738402.085305.608546.618521.134331.201313.121233.879152.35148.93142.077121.45387.24750.747
Gross Profit Ratio 0.4390.5610.490.530.4830.5930.5890.4820.4770.4530.4420.4350.4170.3980.3480.251
Reseach & Development Expenses 43.33448.90438.0137.77736.49944.38346.62646.16350.80626.34317.11416.28315.3713.97800
General & Administrative Expenses 19.55914.8189.69612.94713.95718.57519.98513.31614.03120.6687.0115.0164.4384.38917.2214.216
Selling & Marketing Expenses 133.274155.786117.399118.73598.917205.594200.07103.01189.68274.36535.89328.20124.79518.40314.2526.649
SG&A 152.833240.746127.095131.682112.875224.168220.055116.327103.71495.03342.90433.21729.23222.79231.47220.865
Other Expenses 81.78916.30750.60949.54546.01340.637-4.763.6595.5423.52-3.889-2.7671.1393.9052.350.817
Operating Expenses 277.956305.957215.714219.004195.387309.188307.801197.729194.951141.99770.2758.47353.73644.62532.90221.73
Operating Income 24.117293.271196.548201.428121.741197.576181.915115.954100.43891.76890.30193.26888.28277.01453.52827.177
Operating Income Ratio 0.0350.2750.2220.2660.1920.2140.2060.1690.1530.1780.2620.2720.2590.2520.2130.134
Total Other Income Expenses Net -2.065-0.277-0.223-54.329-68.463-0.717-4.762.581-11.9763.4842.7250.1993.1334.0042.350.817
Income Before Tax 22.052292.994196.325147.09953.278196.86177.156119.613105.39695.25293.02693.46791.41681.01855.87727.994
Income Before Tax Ratio 0.0320.2750.2210.1940.0840.2140.20.1740.1610.1840.270.2730.2680.2660.2230.138
Income Tax Expense 1.55739.81818.12120.1829.46225.14921.60913.2710.61914.14712.83212.91212.83711.3237.8933.894
Net Income 20.495253.176178.204126.91743.816171.71155.546106.34394.77781.10580.19480.55578.57869.69547.98524.1
Net Income Ratio 0.030.2370.2010.1670.0690.1860.1760.1550.1450.1570.2330.2350.2310.2280.1910.119
EPS 0.040.550.570.410.150.610.560.380.340.290.340.380.380.330.240.13
EPS Diluted 0.040.550.570.410.150.60.560.380.340.290.340.380.380.330.240.13
EBITDA 91.74369.463277.983228.312147.592269.433260.192173.753155.05114.145102.645100.73598.43488.27560.56534.868
EBITDA Ratio 0.1330.3460.3140.3010.2330.2930.2940.2530.2360.2210.2980.2940.2890.2890.2410.172